Id proteins in cell growth and tumorigenesis

Cancer Cell

Volumn 3, Issue 6, 2003, Pages 525-530

  Sikder, Hashmat A ^a   Devlin, Meghann K ^a   Dunlap, Shariff ^a   Ryu, Byungwoo ^a   Alani, Rhoda M ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; INHIBITOR OF DIFFERENTIATION PROTEIN; PROTEIN SUBUNIT; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; APOPTOSIS; ASTROCYTOMA; BREAST CARCINOMA; BREAST EPITHELIUM; CARCINOGENESIS; CELL ACTIVITY; CELL AGING; CELL CYCLE; CELL DIFFERENTIATION; CELL GROWTH; CELL MATURATION; CELL TRANSFORMATION; COLORECTAL CARCINOMA; ENDOMETRIUM CARCINOMA; EWING SARCOMA; GENE CONTROL; GENE EXPRESSION; GENE FUNCTION; GENE TARGETING; GENETIC CODE; HUMAN; IN VIVO STUDY; KERATINOCYTE; KNOCKOUT GENE; MALIGNANT NEOPLASTIC DISEASE; MELANOMA; MULTIGENE FAMILY; MUTATIONAL ANALYSIS; MYELOBLAST; NEUROBLAST; NONHUMAN; OVARY CARCINOMA; PANCREAS CANCER; POSTNATAL DEVELOPMENT; PRENATAL DEVELOPMENT; PRIORITY JOURNAL; PROADIPOCYTE; PROMYELOCYTE; PROSTATE CARCINOMA; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; PROTO ONCOGENE; REVIEW; SEMINOMA; SENESCENCE; SQUAMOUS CELL CARCINOMA; TARGET CELL; THYMOCYTE; THYROID CARCINOMA; TRANSGENIC ANIMAL; TUMOR GROWTH; UTERINE CERVIX CARCINOMA;

ANIMALIA;

EID: 0037710310     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1535-6108(03)00141-7     Document Type: Review

References (59)

1. Alani R.M., Hasskarl J., Grace M., Hernandez M.-C., Israel M.A., Munger K. Immortalization of primary human keratinocytes by the helix-loop-helix protein, Id-1. Proc. Natl. Acad. Sci. USA. 96:1999;9637-9641.
2. Alani R.M., Young A.Z., Shifflett C.B. Id1 regulation of cellular senescence through transcriptional repression of p16/Ink4a. Proc. Natl. Acad. Sci. USA. 98:2001;7812-7816.
3. Andres-Barquin P.J., Hernandez M.C., Israel M.A. Id4 expression induces apoptosis in astrocytic cultures and is down- regulated by activation of the cAMP-dependent signal transduction pathway. Exp. Cell Res. 247:1999;347-355.
4. Bader B.L., Rayburn H., Crowley D., Hynes R.O. Extensive vasculogenesis, angiogenesis, and organogenesis precede lethality in mice lacking all alpha v integrins. Cell. 95:1998;507-519.
5. Bain G., Engel I., Robanus Maandag E.C., te Riele H.P., Voland J.R., Sharp L.L., Chun J., Huey B., Pinkel D., Murre C. E2A deficiency leads to abnormalities in alphabeta T-cell development and to rapid development of T-cell lymphomas. Mol. Cell. Biol. 17:1997;4782-4791.
6. Campuzano S. Emc, a negative HLH regulator with multiple functions in Drosophila development. Oncogene. 20:2001;8299-8307.
7. Deed R.W., Hara E., Atherton G.T., Peters G., Norton J.D. Regulation of Id3 cell cycle function by Cdk-2-dependent phosphorylation. Mol. Cell. Biol. 17:1997;6815-6821.
8. Desprez P.Y., Hara E., Bissell M.J., Campisi J. Suppression of mammary epithelial cell differentiation by the helix-loop-helix protein Id-1. Mol. Cell. Biol. 1555:1995;3398-3404.
9. Desprez P.Y., Lin C.Q., Thomasset N., Sympson C.J., Bissell M.J., Campisi J. A novel pathway for mammary epithelial cell invasion induced by the helix-loop-helix protein Id-1. Mol. Cell. Biol. 18:1998;4577-4588.
10. Fukuma M., Okita H., Hata J., Umezawa A. Upregulation of Id2, an oncogenic helix-loop-helix protein, is mediated by the chimeric EWS/ets protein in Ewing sarcoma. Oncogene. 22:2003;1-9.
11. Hacker C., Kirsch R.D., Ju X.S., Hieronymus T., Gust T.C., Kuhl C., Jorgas T., Kurz S.M., Rose-John S., Yokota Y., Zenke M. Transcriptional profiling identifies Id2 function in dendritic cell development. Nat. Immunol. 4:2003;380-386.
12. Hara E., Hall M., Peters G. Cdk2-dependent phosphorylation of Id2 modulates activity of E2A-related transcription factors. EMBO J. 16:1997;332-342.
13. Hu Y.C., Lam K.Y., Law S., Wong J., Srivastava G. Identification of differentially expressed genes in esophageal squamous cell carcinoma (ESCC) by cDNA expression array. overexpression of Fra- 1, Neogenin, Id-1, and CDC25B genes in ESCC Clin. Cancer Res. 7:2001;2213-2221.
14. Israel M.A., Hernandez M.C., Florio M., Andres-Barquin P.J., Mantani A., Carter J.H., Julin C.M. Id gene expression as a key mediator of tumor cell biology. Cancer Res. 59:1999;1726-1730.
15. Kebebew E., Treseler P.A., Duh Q.Y., Clark O.H. The helix-loop-helix transcription factor, Id-1, is overexpressed in medullary thyroid cancer. Surgery. 128:2000;952-957.
16. Kee B.L., Rivera R.R., Murre C. Id3 inhibits B lymphocyte progenitor growth and survival in response to TGF-beta. Nat. Immunol. 2:2001;242-247.
17. Kim D., Peng X.C., Sun X.H. Massive apoptosis of thymocytes in T-cell-deficient Id1 transgenic mice. Mol. Cell. Biol. 19:1999;8240-8253.
18. Langlands K., Down G.A., Kealey T. Id proteins are dynamically expressed in normal epidermis and dysregulated in squamous cell carcinoma. Cancer Res. 60:2000;5929-5933.
19. Lasorella A., Noseda M., Beyna M., Iavarone A. Id2 is a retinoblastoma protein target and mediates signalling by Myc oncoproteins. Nature. 407:2000;592-598.
20. Lasorella A., Uo T., Iavarone A. Id proteins at the cross-road of development and cancer. Oncogene. 20:2001;8326-8333.
21. Lasorella A., Boldrini R., Dominici C., Donfrancesco A., Yokota Y., Inserra A., Iavarone A. Id2 is critical for cellular proliferation and is the oncogenic effector of N-myc in human neuroblastoma. Cancer Res. 62:2002;301-306.
22. Lin C.Q., Singh J., Murata K., Itahana Y., Parrinello S., Liang S.H., Gillett C.E., Campisi J., Desprez P.Y. A role for Id-1 in the aggressive phenotype and steroid hormone response of human breast cancer cells. Cancer Res. 60:2000;1332-1340.
23. Lyden D., Young A.Z., Zagzag D., Yan W., Gerald W., O'Reilly R., Bader B.L., Hynes R.O., Zhuang Y., Manova K., Benezra R. Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts. Nature. 401:1999;670-677.
24. Maruyama H., Kleeff J., Wildi S., Friess H., Buchler M.W., Israel M.A., Korc M. Id-1 and Id-2 are overexpressed in pancreatic cancer and in dysplastic lesions in chronic pancreatitis. Am. J. Pathol. 155:1999;815-822.
25. Morrow M.A., Mayer E.W., Perez C.A., Adlam M., Siu G. Overexpression of the Helix-Loop-Helix protein Id2 blocks T cell development at multiple stages. Mol. Immunol. 36:1999;491-503.
26. Nickoloff B.J., Chaturvedi V., Bacon P., Qin J.Z., Denning M.F., Diaz M.O. Id-1 delays senescence but does not immortalize keratinocytes. J. Biol. Chem. 275:2000;27501-27504.
27. Nishimori H., Sasaki Y., Yoshida K., Irifune H., Zembutsu H., Tanaka T., Aoyama T., Hosaka T., Kawaguchi S., Wada T.et al. The Id2 gene is a novel target of transcriptional activation by EWS-ETS fusion proteins in Ewing family tumors. Oncogene. 21:2002;8302-8309.
28. Norton J.D. ID helix-loop-helix proteins in cell growth, differentiation and tumorigenesis. J. Cell Sci. 113:2000;3897-3905.
29. Norton J.D., Deed R.W., Craggs G., Sablitsky F. Id helix-loop-helix proteins in cell growth and differentiation. Trends Cell Biol. 8:1998;58-65.
30. Ohtani N., Zebedee Z., Huot T., Stinson J., Sugimoto M., Ohashi Y., Sharrocks A., Peters G., Hara E. Opposing effects of Ets and Id proteins on p16Ink4a expression during cellular senescence. Nature. 409:2001;1067-1070.
31. Ouyang X.S., Wang X., Lee D.T., Tsao S.W., Wong Y.C. Over expression of ID-1 in prostate cancer. J. Urol. 167:2002;2598-2602.
32. Pagliuca A., Gallo P., De Luca P., Lania L. Class A helix-loop-helix proteins are positive regulators of several cyclin-dependent kinase inhibitors' promoter activity and negatively affect cell growth. Cancer Res. 60:2000;1376-1382.
33. Pan L., Sato S., Frederick J.P., Sun X.H., Zhuang Y. Impaired immune responses and B-cell proliferation in mice lacking the Id3 gene. Mol. Cell. Biol. 19:1999;5969-5980.
34. Parrinello S., Lin C.Q., Murata K., Itahana Y., Singh J., Krtolica A., Campisi J., Desprez P.Y. Id-1, ITF-2, and Id-2 comprise a network of helix-loop-helix proteins that regulate mammary epithelial cell proliferation, differentiation, and apoptosis. J. Biol. Chem. 276:2001;39213-39219.
35. Polsky D., Young A.Z., Busam K.J., Alani R.M. The transcriptional repressor of p16/Ink4a, Id1, is upregulated in early melanomas. Cancer Res. 61:2001;6008-6011.
36. Prabhu S., Ignatova A., Park S.T., Sun X.H. Regulation of the expression of cyclin-dependent kinase inhibitor p21 by E2A and Id proteins. Mol. Cell. Biol. 17:1997;5888-5896.
37. Rivera R.R., Johns C.P., Quan J., Johnson R.S., Murre C. Thymocyte selection is regulated by the helix-loop-helix inhibitor protein, Id3. Immunity. 12:2000;17-26.
38. Sablitzky F., Moore A., Bromley M., Deed R.W., Newton J.S., Norton J.D. Stage- and subcellular-specific expression of Id proteins in male germ and Sertoli cells implicates distinctive regulatory roles for Id proteins during meiosis, spermatogenesis, and Sertoli cell function. Cell Growth Differ. 9:1998;1015-1024.
39. Schaefer B.M., Koch J., Wirzbach A., Kramer M.D. Expression of the helix-loop-helix protein ID1 in keratinocytes is upregulated by loss of cell-matrix contact. Exp. Cell Res. 266:2001;250-259.
40. Schindl M., Oberhuber G., Obermair A., Schoppmann S.F., Karner B., Birner P. Overexpression of Id-1 protein is a marker for unfavorable prognosis in early-stage cervical cancer. Cancer Res. 61:2001;5703-5706.
41. Schindl M., Schoppmann S.F., Strobel T., Heinzl H., Leisser C., Horvat R., Birner P. Level of id-1 protein expression correlates with poor differentiation, enhanced malignant potential, and more aggressive clinical behavior of epithelial ovarian tumors. Clin. Cancer Res. 9:2003;779-785.
42. Schoppmann S.F., Schindl M., Bayer G., Aumayr K., Dienes J., Horvat R., Rudas M., Gnant M., Jakesz R., Birner P. Overexpression of Id-1 is associated with poor clinical outcome in node negative breast cancer. Int. J. Cancer. 104:2003;677-682.
43. Singh J., Murata K., Itahana Y., Desprez P.Y. Constitutive expression of the Id-1 promoter in human metastatic breast cancer cells is linked with the loss of NF-1/Rb/HDAC-1 transcription repressor complex. Oncogene. 21:2002;1812-1822.
44. Sun X.H. Constitutive expression of the Id1 gene impairs mouse B cell development. Cell. 79:1994;893-900.
45. Takai N., Miyazaki T., Fujisawa K., Nasu K., Miyakawa I. Id1 expression is associated with histological grade and invasive behavior in endometrial carcinoma. Cancer Lett. 165:2001;185-193.
46. Tanaka K., Pracyk J.B., Takeda K., Yu Z.X., Ferrans V.J., Deshpande S.S., Ozaki M., Hwang P.M., Lowenstein C.J., Irani K., Finkel T. Expression of Id1 results in apoptosis of cardiac myocytes through a redox-dependent mechanism. J. Biol. Chem. 273:1998;25922-25928.
47. Tang J., Gordon G.M., Nickoloff B.J., Foreman K.E. The helix-loop-helix protein id-1 delays onset of replicative senescence in human endothelial cells. Lab. Invest. 82:2002;1073-1079.
48. Tang J., Gordon G.M., Muller M.G., Dahiya M., Foreman K.E. Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen induces expression of the helix-loop-helix protein Id-1 in human endothelial cells. J. Virol. 77:2003;5975-5984.
49. Vandeputte D.A., Troost D., Leenstra S., Ijlst-Keizers H., Ramkema M., Bosch D.A., Baas F., Das N.K., Aronica E. Expression and distribution of id helix-loop-helix proteins in human astrocytic tumors. Glia. 38:2002;329-338.
50. Vandesompele J., Edsjo A., De Preter K., Axelson H., Speleman F., Pahlman S. ID2 expression in neuroblastoma does not correlate to MYCN levels and lacks prognostic value. Oncogene. 22:2003;456-460.
51. Volpert O.V., Pili R., Sikder H.A., Nelius T., Zaichuk T., Morris C., Shiflett C.B., Devlin M.K., Conant K., Alani R.M. Id1 regulates angiogenesis through transcriptional repression of thrombospondin-1. Cancer Cell. 2:2002;473-483.
52. Wang Q., Hii G., Shusterman S., Mosse Y., Winter C.L., Guo C., Zhao H., Rappaport E., Hogarty M.D., Maris J.M. ID2 expression is not associated with MYCN amplification or expression in human neuroblastomas. Cancer Res. 63:2003;1631-1635.
53. Wang X., Xu K., Ling M.T., Wong Y.C., Feng H.C., Nicholls J., Tsao S.W. Evidence of increased Id-1 expression and its role in cell proliferation in nasopharyngeal carcinoma cells. Mol. Carcinog. 35:2002;42-49.
54. Wice B.M., Gordon J.I. Forced expression of Id-1 in the adult mouse small intestinal epithelium is associated with development of adenomas. J. Biol. Chem. 273:1998;25310-25319.
55. Wilson J.W., Deed R.W., Inoue T., Balzi M., Becciolini A., Faraoni P., Potten C.S., Norton J.D. Expression of Id helix-loop-helix proteins in colorectal adenocarcinoma correlates with p53 expression and mitotic index. Cancer Res. 61:2001;8803-8810.
56. Yan W., Young A.Z., Soares V.C., Kelley R., Benezra R., Zhuang Y. High incidence of T-cell tumors in E2A-null mice and E2A/Id1 double-knockout mice. Mol. Cell. Biol. 17:1997;7317-7327.
57. Yokota Y. Id and development. Oncogene. 20:2001;8290-8298.
58. Yokota Y., Mansouri A., Mori S., Sugawara S., Adachi S., Nishikawa S., Gruss P. Development of peripheral lymphoid organs and natural killer cells depends on the helix-loop-helix inhibitor Id2. Nature. 397:1999;702-706.
59. Zebedee Z., Hara E. Id proteins in cell cycle control and cellular senescence. Oncogene. 20:2001;8317-8325.